Wolff AC - Search Results

1

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.

Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, De Cubas AA, Xia Y, Felsheim BM, McClure MB, Rajkovic A, Karaesmen E, Smith MA, Fan C, Ericsson PIG, Sanders ME, Creighton CJ, Bowen J, Leraas K, Burns RT, Coppens S, Wheless A, Rezk S, Garrett AL, Parker JS, Foy KK, Shen H, Park BH, Krop I, Anders C, Gastier-Foster J, Rimawi MF, Nanda R, Lin NU, Isaacs C, Marcom PK, Storniolo AM, Couch FJ, Chandran U, Davis M, Silverstein J, Ropelewski A, Liu MC, Hilsenbeck SG, Norton L, Richardson AL, Symmans WF, Wolff AC, Davidson NE, Carey LA, Lee AV, Balko JM, Hoadley KA, Laird PW, Mardis ER, King TA; AURORA US Network; Perou CM. Garcia-Recio S, et al. Among authors: wolff ac. Nat Cancer. 2023 Jan;4(1):128-147. doi: 10.1038/s43018-022-00491-x. Epub 2022 Dec 30. Nat Cancer. 2023. PMID: 36585450 Free PMC article.

2

Primary systemic therapy in operable breast cancer.

Wolff AC, Davidson NE. Wolff AC, et al. J Clin Oncol. 2000 Apr;18(7):1558-69. doi: 10.1200/JCO.2000.18.7.1558. J Clin Oncol. 2000. PMID: 10735905 Review.

3

New data on adjuvant therapy for breast cancer.

Wolff AC, Davidson NE. Wolff AC, et al. Curr Oncol Rep. 1999 Sep;1(1):31-7. doi: 10.1007/s11912-999-0007-5. Curr Oncol Rep. 1999. PMID: 11122795 Review.

4

Use of SERMs for the adjuvant therapy of early-stage breast cancer.

Wolff AC, Davidson NE. Wolff AC, et al. Ann N Y Acad Sci. 2001 Dec;949:80-8. doi: 10.1111/j.1749-6632.2001.tb04005.x. Ann N Y Acad Sci. 2001. PMID: 11795384 Review.

5

Early operable breast cancer.

Wolff AC, Davidson NE. Wolff AC, et al. Curr Treat Options Oncol. 2000 Aug;1(3):210-20. doi: 10.1007/s11864-000-0032-y. Curr Treat Options Oncol. 2000. PMID: 12057163 Review.

6

Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease.

Wolff AC, Davidson NE. Wolff AC, et al. Oncologist. 2002;7(3):239-45. doi: 10.1634/theoncologist.7-3-239. Oncologist. 2002. PMID: 12065797 Free article. Review.

7

A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer.

Wolff AC, Armstrong DK, Fetting JH, Carducci MK, Riley CD, Bender JF, Casero RA Jr, Davidson NE. Wolff AC, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5922-8. Clin Cancer Res. 2003. PMID: 14676116 Clinical Trial.

8

Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193.

Wolff AC, O'Neill A, Kennedy MJ, Stewart JA, Gradishar WJ, Lord RS 3rd, Davidson NE, Wood WC. Wolff AC, et al. Clin Breast Cancer. 2005 Oct;6(4):334-9. doi: 10.3816/CBC.2005.n.037. Clin Breast Cancer. 2005. PMID: 16277884 Clinical Trial.

9

Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.

Wolff AC, Davidson NE. Wolff AC, et al. J Clin Oncol. 2006 Nov 1;24(31):4949-51. doi: 10.1200/JCO.2006.07.9160. J Clin Oncol. 2006. PMID: 17075110 No abstract available.

10

The impact of sharing results of a randomized breast cancer clinical trial with study participants.

Partridge AH, Wolff AC, Marcom PK, Kaufman PA, Zhang L, Gelman R, Moore C, Lake D, Fleming GF, Rugo HS, Atkins J, Sampson E, Collyar D, Winer EP. Partridge AH, et al. Among authors: wolff ac. Breast Cancer Res Treat. 2009 May;115(1):123-9. doi: 10.1007/s10549-008-0057-7. Epub 2008 Jun 10. Breast Cancer Res Treat. 2009. PMID: 18543100 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters